This event has run. Thank you to our speakers, sponsors, and delegates who joined us for the 2026 summit.

Radiopharm Doses First Patient in Phase I Prostate Cancer Radiotherapy Study
Alpha‑Emitting PSMA Therapies Gain Momentum Across Radiopharma Leaders
Ratio Therapeutics Highlights the Next Wave of Radiopharmaceutical Manufacturing Standards
Radiopharma Veterans From Novartis‑Built Platforms Strengthen Emerging Biotechs
Radiopharma Takes Center Stage as Global Biopharma Partnering Accelerates

Managing Toxicity & Therapeutic Index in Radioligand Therapy Clinical Development to Improve Patient Outcomes Whilst Retaining Efficacy

Managing Toxicity & Therapeutic Index in Radioligand Therapy Clinical Development to Improve Patient Outcomes Whilst Retaining Efficacy

10:59 am - Thursday 23rd July 2026

Speakers:

Jessica Guarnaschelli

Jessica Guarnaschelli

Independent Consultant

CURADH Pharmaceuticals